Alignment Healthcare (NASDAQ:ALHC) President Sells $3,539,013.42 in Stock

Key Points

• Dawn Christine Maroney, President of Alignment Healthcare, sold 215,662 shares of the company's stock at an average price of $16.41, totaling approximately $3.54 million, which reflects a 10.71% decrease in her ownership.
• Alignment Healthcare's shares recently traded down 0.2% to $16.45, with a fifty-two week price range between $8.82 and $21.06, while the company reported a 49% increase in quarterly revenue year-over-year.
• Wall Street analysts have expressed varying opinions on the stock, with several upgrades, leading to a consensus rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 215,662 shares of the business's stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the sale, the president owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. This represents a 10.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, July 14th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.44, for a total value of $403,200.00.
• On Monday, June 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $14.48, for a total value of $434,400.00.

Alignment Healthcare Price Performance

ALHC stock traded up $0.28 during trading on Monday, hitting $16.32. The company had a trading volume of 4,336,879 shares, compared to its average volume of 3,638,717. The company has a fifty day moving average price of $14.47 and a two-hundred day moving average price of $15.54. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a market cap of $3.23 billion, a P/E ratio of -58.28 and a beta of 1.17. Alignment Healthcare, Inc. has a fifty-two week low of $9.15 and a fifty-two week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare's quarterly revenue was up 49.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently made changes to their positions in the company. MCF Advisors LLC lifted its stake in shares of Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after acquiring an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Alignment Healthcare during the first quarter valued at $42,000. SBI Securities Co. Ltd. lifted its stake in shares of Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company's stock valued at $42,000 after acquiring an additional 2,970 shares during the period. KBC Group NV acquired a new position in shares of Alignment Healthcare during the second quarter valued at $44,000. Finally, Signaturefd LLC lifted its stake in shares of Alignment Healthcare by 142.6% during the second quarter. Signaturefd LLC now owns 3,768 shares of the company's stock valued at $53,000 after acquiring an additional 2,215 shares during the period. Institutional investors and hedge funds own 86.19% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Zacks Research raised Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. KeyCorp raised Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target on the stock in a research note on Monday, August 25th. Wall Street Zen lowered Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price objective for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.